SUPERCALY DAILY BRIEF · #009 345面霜：品牌自报全球累计超3500万件345 cream: brand reports 35m+ cumulative global units 2026-10-02 · 中英双语日报 / Bilingual daily brief |
Dr.Althea于9月16日自报345 Relief Cream全球累计销量超3500万件，起止日期未披露；并非美国销量，未经独立核实。 On September 16, Dr.Althea reported over 35 million cumulative worldwide units of 345 Relief Cream sold. The start and end dates are undisclosed; this is not a US sales figure and is not independently verified. |
01 · 产品与售价 / Product and price 美国零售：单支与双支装US retail: single and two-pack 
品牌产品图，非本刊实拍。 Brand image; not our photograph. 10月2日品牌美国站：50ml单支27美元，双支45.90美元，均为零售价。 On October 2, the brand’s US storefront lists one 50ml tube at $27 and two at $45.90, both retail prices. 品牌将其定位为面向易长痘、敏感肌的轻盈日常保湿霜。分析：明确的使用需求配合双支选择，让产品卖点易懂；这不能证明其累计销量的成因。 The brand positions it as a lightweight daily moisturizer for blemish-prone, sensitive skin. Analysis: a specific daily need and a two-tube option make the offer understandable; they do not establish what caused cumulative sales. |
| SuperCaly Daily Brief · #009 资料核查于 2026-10-02。销售与研究时段以各条正文标注为准。 Sources checked on 2 October 2026. Sales and research periods are identified in each story. |